Optimapharm
OptimaCardio Suite
Partnered on
81
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
84
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Approved Cardiovascular Therapies

OptimaCardio Suite introduces a fully integrated cardiovascular Full Service CRO ecosystem that unites leading cardiology experts, high-performing research sites, advanced digital tools, and engaged patient communities into one seamless platform. Built to streamline operations, accelerate study start-up, strengthen evidence generation, and enhance patient involvement, it redefines what cardiovascular trial support can look like. By connecting every stakeholder across the cardiology research journey, OptimaCardio Suite transforms complexity into coordinated, data-driven progress

80+ Cardiology Projects
12,000+ Patients Enrolled
OptimaOnco Suite Distribution

Strategic Advisory Board

Dr. Pavle Vukojević

Dr. Pavle Vukojević

Chief Medical Officer

Dr. Martin Borovec

Dr. Martin Borovec

Medical Advisor

Dr. George Thornton

Dr. George Thornton

Medical Advisor

Dr. Mariam Pitava

Dr. Mariam Pitava

Strategic Advisor

Dr. Robert Walsh

Dr. Robert Walsh

Medical Advisor

Patient Advisory Board

Optimapharm has established a dedicated Patient Advisory Board, which we actively collaborate with and support to ensure patients' perspectives are reflected throughout development. By embedding their voice into clinical trial protocols and study execution, we help shape research that is more accessible, meaningful and aligned with the needs of those it aims to serve

Patient Advisory Board
Sandra Silva-Arrieta - Patient Advisory Board Lead

We Proudly Support

Aortic Hope – We Proudly Support

Site & Patient Referral Networks

Optimapharm strategically partners with diverse site networks, including community-based recruitment organisations, site management organisations, and leading hospital systems, to deliver faster and more seamless study execution. With twice the reach across North America and Europe compared with the average mid-sized CRO, we expand access to patients where they live and receive care, enabling broader enrolment and real-world representation. These collaborative partnerships drive accelerated start-up, stronger referral pathways and a consistently high-performing site experience.

Site & Patient Referral Networks Map
Accelerated START-UP
Growth Chart

2xThe reach of the average mid-sized CRO in North America and Europe

Healthcare Professional

Accelerating delivery through patient reach and expanded access to regulatory frameworks

Data Visualisations

BI Wizard

BI Wizard is our custom-built analytics solution, developed and powered by Microsoft Power BI. It leverages Power BI's robust business intelligence platform to visualise data, share insights, and provide interactive dashboards and reports. With BI Wizard, both Optimapharm and our sponsors can easily explore and interact with data, supporting informed, data-driven decision-making on all sides

Operational Insights

Example Report (Enrolment)
Enrolment Report

Patient Profiling

Example Report (Blood Pressure)
Blood Pressure

Endpoint & Outcome Measures

Central Imaging

Central Imaging
Regulatory-grade cardiac imaging
AI-enabled endpoint precision
End-to-end trial delivery
STRATEGIC PARTNER
Quibim

Central Laboratory

Central Laboratory
CAP Certified global laboratories
Health Institution for LDT/IVDR
PBMC Network
Large range of Broad Biomarker Capabilities
STRATEGIC PARTNER
mlm medical labs

Resource Hub